Apexigen Common Stock

The latest common stock for APGN is $2K as of June 2023. That compares with $52B in the prior-year period — down 100.0% year over year. Investors often review this figure alongside Apexigen's historical trend and sector peers before judging valuation or financial health.

Over the past year, APGN's common stock moved from $52B to $2K — a 100.0% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Apexigen's operating scale or balance-sheet position.

A common stock figure of $2K for APGN is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting APGN's common stock ($2K), review year-over-year change from $52B, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.